Your launch strategy has never met the competition
Will your launch strategy work once it has finally left the meeting room and met the competition?
Newsletters and Deep Dive digital magazine
Will your launch strategy work once it has finally left the meeting room and met the competition?
Jonah Comstock reunited with Dr Michael Bauer, CEO of Quantro Therapeutics, at LSX 2026 to discuss the company's progress.
Shai Melcer discusses bioconvergence, a multidisciplinary research and development approach that merges technologies.
Industry must build custom solutions that leverage a pharmaceutical business’ unique assets – including its people.
A new generation of in vivo CAR-T cell technologies promises to remove some of the biggest practical barriers to conventional cell therapy.
Editor's Picks
Newsletters and Deep Dive
digital magazine